CODX vs EXAS · rev $3.9M vs rev $2.76B
Co-Diagnostics, Inc. Common Stock (CODX) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
CODX currently screens at market cap $31.4M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the CODX and EXAS stock pages for the full models.
Not investment advice.